UP202-56
Modify Date: 2025-08-25 11:38:39
UP202-56 structure
|
Common Name | UP202-56 | ||
|---|---|---|---|---|
| CAS Number | 163838-04-8 | Molecular Weight | 594.7 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C34H38N6O4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of UP202-56UP202-56 is an adenosine analogue, which is an adenosinergic agonist. |
| Name | UP202-56 |
|---|
| Description | UP202-56 is an adenosine analogue, which is an adenosinergic agonist. |
|---|---|
| Related Catalog | |
| Target |
Adenosine Receptor[1][2] |
| In Vitro | The effects of oral administration of UP202-56, an adenosine analogue, are assessed on carrageenan-induced spinal c-Fos protein expression and peripheral oedema. Oral UP202-56 (10, 30 or 50 mg/kg) dose-dependently reduces the number of carrageenan-induced c-Fos like immunoreactivity (c-Fos-LI) neurons (r=0.931. P<0.0001), with the highest dose of UP202-56 producing 72±4% reduction of the total number of carrageenan-induced spinal c-Fos-LI neurons, and 12±3% and 33±6% of reduction of control carrageenan oedema at paw and ankle levels, respectively. UP202-56 dose-dependently reduces the spinal c-Fos protein expression in carrageenan model of inflammatory pain[1]. UP202-56 is an adenosinergic agonist[2]. |
| References |
| Molecular Formula | C34H38N6O4 |
|---|---|
| Molecular Weight | 594.7 |
| InChIKey | JULMZFRVKFLKMZ-IMNMKIORSA-N |
| SMILES | Cc1ccc(C)c(Cn2cc(CCNc3ncnc4c3ncn4C3OC(C(=O)CC4CC4)C(O)C3O)c3cc(C)ccc32)c1 |
| Storage condition | 2-8℃ |